DIA-39-C20
$450.00
Dual agonists in this class are widely studied in pharmacology for their ability to regulate blood glucose, stimulate insulin secretion in a glucose-dependent manner, suppress appetite, and reduce body weight.
99%+
PURITY
GUARANTEED
7
QUALITY
CHECKS
100%
U.S.
SOURCED
For research use only. Not for human consumption. Products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are 21+ and conducting legitimate laboratory research.
Product Information
Benefits DIA-39-C20
- Superior Glycemic Control: By activating both GLP-1 and GIP receptors, it stimulates insulin production and suppresses glucagon release, which effectively normalizes high blood sugar levels.
- Significant Weight Loss: The dual action enhances satiety, delays stomach emptying, and reduces food cravings. It consistently outperforms pure GLP-1 medications in total body weight reduction.
- Cardiovascular & Metabolic Health: Beyond weight and sugar management, dual agonists can reduce blood pressure, lower harmful lipids, and decrease the risk of cardiovascular events.
- Convenience: Due to strategic modifications (such as a stabilizing backbone and fatty acid side chains), the medication requires only a once-weekly subcutaneous injection.
Potential Side Effects
- Nausea, vomiting, and diarrhea(especially when beginning the medication)
- Abdominal pain or bloating
- Constipation
- Fatigue or dizziness
- Decreased appetite
Dosage
Start off at 2.5mg for 4 weeks, if ineffective after 4 weeks you increase your dose by 2.5mg.
